A Review of Cytotoxic Plants of the Indian Subcontinent and a Broad-Spectrum Analysis of Their Bioactive Compounds.
Kishor MazumderBiswajit BiswasIqbal Mahmud RajaKoichi FukasePublished in: Molecules (Basel, Switzerland) (2020)
Cancer or uncontrolled cell proliferation is a major health issue worldwide and is the second leading cause of deaths globally. The high mortality rate and toxicity associated with cancer chemotherapy or radiation therapy have encouraged the investigation of complementary and alternative treatment methods, such as plant-based drugs. Moreover, over 60% of the anti-cancer drugs are molecules derived from plants or their synthetic derivatives. Therefore, in the present review, an attempt has been made to summarize the cytotoxic plants available in the Indian subcontinent along with a description of their bio-active components. The review covers 99 plants of 57 families as well as over 110 isolated bioactive cytotoxic compounds, amongst which at least 20 are new compounds. Among the reported phytoconstituents, artemisinin, lupeol, curcumin, and quercetin are under clinical trials, while brazilin, catechin, ursolic acid, β-sitosterol, and myricetin are under pharmacokinetic development. However, for the remaining compounds, there is little or no information available. Therefore, further investigations are warranted on these subcontinent medicinal plants as an important source of novel cytotoxic agents.
Keyphrases
- papillary thyroid
- radiation therapy
- clinical trial
- cell proliferation
- squamous cell
- healthcare
- public health
- health information
- mental health
- randomized controlled trial
- locally advanced
- lymph node metastasis
- type diabetes
- social media
- cardiovascular disease
- coronary artery disease
- radiation induced
- drug induced
- risk assessment
- phase ii
- smoking cessation
- replacement therapy